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Cardiac troponin T (TNNT2) mutations in Chinese dilated cardiomyopathy
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Objectives: Dilated cardiomyopathy (DCM) is one of the leading causes of heart
failure with high morbidity and mortality. Although more than 40 genes have been
reported to cause DCM, the role of genetic testing in clinical practice is not well
deﬁned. Mutations in the troponin T (TNNT2) gene represent an important subset of
known disease-causing mutations associated with DCM. Therefore, the aim of the
present study was to determine the genetic variations in TNNT2 and the associations
of those variations with DCM in Chinese patients.
Methods: An approximately 4 kb fragment of the TNNT2 gene was isolated from 103
DCM patients and 192 healthy controls and was analyzed by DNA sequence analysis
for genetic variations.
Results: A total of 6 TNNT2 variants were identiﬁed in 99 patients, including a
G321T missense mutation (Leu84Phe) and 5 novel intronic variants. Alleles of two
novel SNPs (c.192+353 C>A, OR¼0.095; 95% CI: 0.013-0.714, P¼0.022;
c.192+463 G>A, OR¼0.090, 95% CI: 0.012-0.675, P¼0.019) and SNP rs3729843
(OR¼1.889, 95% CI: 1.252-2.852; P¼0.002) were signiﬁcantly correlated with DCM.
Conclusions: These results suggest that variations in the TNNT2 gene might be
associated with DCM in the Chinese population.
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Angiotension II upregulates the Hyperpolarization-Activated Cyclic Nucleotide-
Gated Channel in Neonatal Rat Cardiomyocytes via a redox mechanism
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Objectives: To identify the effects of exogenous Angiotension II (AngII) on the
Hyperpolarization-Activated Cyclic Nucleotide-Gated Channel (HCN) current and its
mechanisms in Neonatal Rat Ventricle Cardiomyocytes (NRVM).
Methods: NRVM from 1- to 3-day-old Wister rats were prepared by collagenase
digestion, and incubated in 37C, 95% CO2 for If current by using of patch-clamp
recording, HCN channel protein expression was detected by western-blotting analysis.
Results: exposure (w20 min) of NRVM to AngII (100 mmol/L) markedly increased If
density (4.70.6 pA/pF vs. 11.71.1 pA/pF) along increased conductance (Gmax:
48.75.6 pS/pF vs. 192.664.1 pS/pF), a shift in activation voltage (V1/2) to positive
potentials (-81.21.6 mV vs. -64.72.0 mV) and increase rate of activation (tact)
(523.424.7 ms vs. 337.524.9 ms). Moreover, stimulation by AngII was largely
inhibited by the non-speciﬁc tyrosine kinase blocker genistein (1mmol/L) or the c-Src-
speciﬁc inhibitor PP2 (10 mmol/L). Augmented tyrosine phosphorylation of HCN2
channels with AngII treatment by determined by AngII Western blot using the
phosphotyrosine speciﬁc antibody 4G10. Furthermore, the augmented If current was
inhibited by pre-treatment with Trx receptor inhibitor (Auranoﬁn 10nmol/L; 13-cis-
retinoic acid 1 mmol/L). On the other hand, If current of NRVMs was also increased by
treated with non-speciﬁc PTP inhibitors, phenylarsine oxide (PAO 1 mmol/L) or
Na-orthovanadate (Na3VO4 10 mmol/L).
Conclusions: These data suggest that the c-Src family of tyrosine kinase mediate the
augmentation of If density by oxidant agent AngII via a redox mechanism involving
the Trx system. The studies will provide new insights into the relation of oxidative cell
damage and ion channel remodeling.
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Objectives: Declined vasorelaxation function in aging resistance arteries is respon-
sible for aging related multiple organ dysfunctions. The aim of the present study is to
explore the role of peroxynitrite (ONOO-) in aging resistance arterial vasorelaxation
dysfunction and the possible mechanism.
Methods: In the present study, young (3-4 months olds) and aging (20 months olds)
male SD rats were randomly randomized to receive vehicle (Saline) or FeTMPyP
(ONOO- scavenger) for 2 weeks. The vasorelaxation of resistance arteries was
determined in vitro; NOx level was tested by a colorimetric assay; the expression of
nitrotyrosine (NT), soluble Guanylate Cyclase (sGC), vasodilator-stimulated phos-
phoprotein (VASP) and phosphorylated VASP (P-VASP) in resistance arteries was
detected by immunohistochemical staining.C42 JACC Vol 64/16/Suppl C j OctobResults: In the present study, endothelium dependent dilation in aging resistance
arteries was lower than young rats (young vs. aging: 68.0%4.5% vs. 50.4%2.9%,
P<0.01). And the endothelium independent dilation remained constant. Nitrative stress
was increased in aging resistance arteries, evidenced by elevated NOx level in serum
from aging rats (nmol/ml; young vs. aging: 3.31.4 vs. 5.31.0, P<0.05) and
increased NT level (P<0.05). ONOO- was responsible for the vasorelaxation
dysfunction, evidenced by normalized vasorelaxation after inhibit ONOO- or its
sources (P<0.05) and suppressed NT expression after FeTMPyP treatment (P<0.05).
The expression of sGC was not signiﬁcantly different between young and aging
resistance arteries, but the P-VASP/VASP ratio (biochemical marker of NO-sGC-cGKs
signaling) decreased, which was reversed by FeTMPyP treatment in vivo (P<0.05).
Conclusions: The present study suggested that ONOO- is responsible for the decline
of endothelial dependent vasorelaxation in aging resistance arteries, and this effect
likely involves the dysfunction of the NO-sGC-cGKs pathway.
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Silk ﬁbroin/chitosan nanoﬁbers based adipose tissue-derived mesenchymal stem
cell patches prevent myocardial remodeling after myocardial infarction in rat
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Objectives: To fabricate novel biocompatible silk ﬁbroin/chitosan (SF/CS) nanoﬁbers
seeded with adipose tissue-derived mesenchymal stem cells (AD-MSCs) for cardiac
tissue regeneration.
Methods: Silk ﬁbroin with good elasticity and chitosan as hydrophile were assembled
onto the cellulose electrospun mat via layer-by-layer method. The micro-structure of
the nanoﬁbers was characterized by X-ray photoelectron spectroscopy (XPS) and
scanning electron microscope (SEM). AD-MSCs were isolated from Fluc-EGFP
transgenic mice constitutively expressing both ﬁreﬂy luciferase (Fluc) and enhanced
green ﬂuorescent protein (EGFP). Rat model of acute myocardial infarction (AMI)
was induced by ligation of the left anterior descending coronary artery. The SF/CS
nanoﬁbrous patches (99mm2) seeded with or without ADMSCs (seeding density:
2105 cells/patch) were adhered onto the epicardium of the infarcted region. Wild
type Sprague Dawley rats (male, 120-140g) were randomized into four groups (each
n¼10) : Sham group, MI group, MI/SF/CS group and MI/ADMSC/SF/CS group (MI
hearts with implantations of SF/CS and ADMSC/SF/CS patches respectively). Three
days post-operation, cardiomyocyte apoptosis and the paracrine factors in the peri-
infarct area was determined by TUNEL staining and by ELISA assay respectively.
The viability of engrafted AD-MSCs was tracked using longitudinal bioluminescence
imaging (BLI) and cardiac function was measured by transthoracic echocardiography
(TTE) 1, 7, 14 and 28 days post-operation. Four weeks after AMI operation, H&E,
Masson’s Trichrome, Troponin I, CD68 and CD31 immunoﬂuorescence stainings
were performed to evaluate myocardium ﬁbrosis, tissue regeneration, neovas-
cularization and inﬂammatory reaction.
Results: BLI showed AD-MSCs were detectable until four weeks after transplantation.
By TTE, ADMSC/SF/CS patches improved left ventricular ejection fraction (LVEF)
(sham: 732%, MI: 243%, MI/SF/CS: 383%, MI/ADMSC/SF/CS: 534%; n¼10
per group; P<0.05, four weeks post-operation). The implantation of ADMSC/SF/CS
patches decreased cardiomyocyte apoptosis (P<0.05) and increased the secretion of
paracrine factors (P<0.05). Four weeks after operation, the patches in both groups
were intactly adhered on the MI zones with minor inﬂammatory as compared with MI
group (P<0.05), while angiogenesis was improved (P<0.05) and ﬁbrosis size was
reduced (sham: 0, MI: 234%, MI/SF/CS: 152%, MI/ADMSC/SF/CS: 9 3 %;
n¼10 per group; P<0.05). Furthermore, EGFP+ cardiomyocytes (cTn I-positive) and
endothelial cells (CD31-positive) could be identiﬁed in MI/ADMSC/SF/CS group.
Conclusions: This study demonstrated that the SF/CS nanoﬁbers provide three-
dimensional microenvironments and scaffold to support the retention and viability of
engrafted ADMSCs, synergistically promote the therapeutic efﬁciency to alleviate
cardiac ﬁbrosis, attenuate ventricular remodeling and induce angiogenesis and car-
diomyocyte regeneration.
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Objectives: Oxidative stress can induce endothelial cell injury. Plasminogen activator
inhibitor-1 (PAI-1), a serine protease inhibitor, accelerates thrombus formation upon
ruptured atherosclerotic plaques. However, it is not known whether or not ginsenoside
Rb1 inhibits PAI-1 production induced by H2O2 in endothelial cells. In present study,
we investigated that Rb1 may have an inhibitory effect on PAI-1 production induced
by H2O2 and have protective effects on H2O2-induced endothelial injury.
Methods: Primary human umbilical vein endothelial cells (HUVECs) injury was
induced by H2O2. PAI-1 mRNA and protein expression were analyzed by real time
PCR and Western blot.
Results: Rb1 was found to protect endothelial injury, as witnessed by a signiﬁcant
increase of cell numbers. Rb1 could markedly decrease PAI-1 mRNA expression byer 16–19, 2014 j GW-ICC Abstracts/Basic and Translational Medicine
1.56-fold compared with cells treated with H2O2 alone after 24-hour incubation
(P<0.01). Meanwhile, PAI-1 protein expression decreased in the 20mM Rb1-
pretreated cells by 1.39-fold compared to that in cells treated with H2O2 alone (P<0.01).
Conclusions: Our report demonstrates that Rb1 can exert protective effects on H2O2-
induced cellular injury through modulating PAI-1 expression.
GW25-e4168
Dipeptidyl peptidase (DPP) -4 inhibitor exhibits anti-apoptosis effects in
isoproterenol-induced myocardial infarcted rats by inhibiting oxidative stress
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Objectives: Cardiac apoptosis plays an important role in the pathology of myocar-
dial infarction. The protective effects of Dipeptidyl peptidase (DPP) -4 inhibitor
(vildagliptin) on cardiac apoptosis were evaluated in isoproterenol induced myocardial
infarcted rats.
Methods: Male Wistar rats are treated intravenously with Vildagliptin (2 mg/kg/day)
daily for a period of 21 days. After 21 days of pretreatment, isoproterenol (100 mg/kg)
was injected subcutaneously to rats at an interval of 24 h for 2 days (on 22th and 23th
day) to induce myocardial infarction. Cardiac diagnostic markers, heart lipid peroxi-
dation, antioxidant system, histopathological changes of the heart and apoptosis were
evaluated in isoproterenol induced myocardial infarcted rats.
Results: Isoproterenol induced myocardial infarcted rats showed a signiﬁcant increase
in the levels of serum cardiac diagnostic markers, heart lipid peroxidation products and a
signiﬁcant decrease in the activities/levels of heart antioxidants, compared with normal
rats. Additionally, Histopathological ﬁndings of myocardial infarcted rats revealed
marked necrosis. Real Time Polymerase Chain Reaction study revealed an increase in
the myocardial expression of Bax, caspase-8, caspase-9 and Fas genes and a decrease in
the myocardial expression of Bcl-2 and Bcl-xL genes.Vildagliptin (2 mg/kg/day) pre-
treatment decreased the levels of serum cardiac marker enzymes, reduced heart lipid
peroxidation and minimized the alterations the activities/levels of heart antioxidants of
isoproterenol-induced myocardial infarcted rats. Histopathological study evidenced that
the pretreatment with Vildagliptin inhibited myocardial damage. Vildagliptin pre-
treatment also showed protective effects on apoptosis. The in vitro study also revealed
the free radical scavenging and anti-apoptosis activity of Vildagliptin.
Conclusions: Thus, Vildagliptin protected the myocardial infarcted rat’s heart against
apoptosis by inhibiting oxidative stress.
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Objectives: The interactional relationship between the sympathetic nervous systems
(SNS) and the renin-angiotensin-aldosterone system (RAS) has been revealed but
poorly investigated. The present work was designed to explore the effect of meto-
prolol (MET) treatment on the RAS, especially the expression and vasomotor function
of AT2R, in spontaneously hypertensive rats (SHR).
Methods: SHR was treated with metoprolol for 4 weeks. The dynamic changes of the
blood pressure, renin activity, Ang II concentration and AT2R expression were
investigated. Superior mesenteric resistance arteries were isolated for determining the
protein expression of AT1R and AT2R. Perfusion experiment was carried out to
explore the vasomotor function of AT2R.
Results: The results showed that up-regulated renin activity and Ang II concentration
of plasma in SHR were inhibited by metoprolol treatment. In isolated superior
mesenteric arteries from both WKY and SHR, Ang II perfusion induced vasodilatation
after AT1R inhibition by telmisartan, although the vasodilatation was harmed in SHR.
Furthermore, AT2R inhibitor PD123319 arrested the vasodilatation induced by Ang
II. SHR received metoprolol exerted improved vasodilatation mediated by AT2R
(47.295.16% versus 24.994.93% for MET and SHR, respectively, P<0.05).
Western blot analysis showed that metoprolol restored expression of AT2R in SHR,
which may contribute to metoprolol’s antihypertensive effect.
Conclusions: These results suggested an impact of b-adrenergic blocker on RAS and
supported an important role of AT2R in antihypertensive treatment.
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Action and Mechanism of Secreted Frizzled-Related Protein 5 in Cardiomyocyte
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Objectives: Secreted frizzled-related protein 5 (Sfrp5) has been described as novel
adipokine with anti-inﬂammatory properties at present. However, it’s expression and
protection mechanisms in the cardiomyocyte hypertrophy at the cellular level are not
thoroughly understood. Here, the authors report for the ﬁrst time by means of
angiotensin II induced cardiomyocyte hypertrophy in vitro that the expression and
mechanisms of Sfrp5.JACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/BMethods: Cardiomyocytes were preincubated with Ang II through primary culture of
cardiac cells of neonatal SD rats. Telmisartan and PD123319 were used to block Ang
II type-1 and type-1 receptors respectively. Rho proteins have been suggested as major
contributors to cardiac hypertrophy. Here, inhibition of the Rho/ROCK pathway by
Y-27632, a selective inhibitor of ROCK, we determined the hypothesis that Rho and
Rho-associated kinase (Rho/ROCK) as mediators of the expression of sFRP5 in
angiotensin II (Ang II) -induced cardiomyocyte hypertrophy. Reverse transcription-
polymerase chain reaction and Western blot were used to estimate the expression of
sfRP5, brain natriuretic peptide (BNP) and phosphorylation of MYPT-1.
Results: sFRP5 was discovered expressed in cardiomyocytes. Ang II treatment
induced the increased expression of sFRP5 and BNP in a dose-and time-dependent
manner in cardiomyocytes, after preincubating with AT1-R antagonist telmisartan
completely blocked Ang II-induced sFRP5 expression increasement. The recession of
phosphorylation of MYPT-1 (P-MYPT 1) and sFRP5 were expressed after inhibiting
of Rho/ROCK.
Conclusions: The increased sFRP5 expression was mainly through the AT1-R-Rho/
ROCK signal pathway in the process of Ang IIinduced cardiomyocyte hypertrophy.
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The research on antihypertensive effect of metoprolol inﬂuenced by knockdown
of b1-AR in myocardial tissue of Spontaneously Hypertensive Rats
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Objectives: To investigate the effect of knockdown of b1-AR in myocardium on
metoprolol antihypertension of SHRs.
Methods: (1) Construct pAAV-ZsGreen-ADRB1-shRNA plasmid; pAAV-ZsGreen-
ADRB1-shRNA plasmid was constructed according to shRNA principle and b1-AR
coding sequence in Genebank. Conﬁrmed by enzyme digestion and gene sequencing,
showing that 100% identical to its accession number. The plasmid was then packaged
to recombinant adeno-associated virus named AAV9- shRNA-ADRB1-ZsGreen and
harvested (viral titer was 1.5x1012vg/ml). (2) Spontaneousely Hypertensive Rats
treatments; 36 SHRs were grouped into six randomly as follows:Group 1, AAV9-
shRNA-ADRB1-ZsGreen + metoprolol (n¼6); Group2, AAV9-shRNA-ADRB1-
ZsGreen+saline (n¼6); Group 3, AAV9-CMV-ADRB1- ZsGreen + metoprolol
(n¼6); Group 4, AAV9-CMV-ADRB1-ZsGreen + saline Group (n¼6); Group 5,
sham + metoprolol Group (n¼6); Group 6, sham + saline (n¼6). Metoprolol were
given by gavage in 50mg/kg/d dose. All of them were monitored their blood pressure
weekly. Rats were killed and dissected the myocardial tissue after 4 weeks. (3) The
research on the expression of b1-AR in myocardial tissue among all rats groups in
transcription and translation levels, Real-time RT-PCR, Immunohistochemistry and
Western blot were used to assay the expression of b1-AR gene.
Results: (1) Comparison of the b1-AR expression among each group: Real-time
RT-PCR results showed that AAV9-shRNA-ADRB1-ZsGreen injection could
signiﬁcantly decrease b1-AR mRNA expression compared with the negative control
group (P <0.05) Immunohistochemistry results showed that it could signiﬁcantly
decrease theb1-AR protein expression compared with the negative control and sham
group (P <0.05 ), Western blot results showed that it also could signiﬁcantly decrease
the b1-AR protein expression compared with the negative control group (P <0.05).
(2) Comparison of the antihypertensive effects among each group: After 4 weeks of
the intervention, systolic blood pressure in group 1, group 2, group 3, group 5 was
signiﬁcantly lower than group 4 and group 6 (P<0.05); After 4 weeks of metoprolol
intervention, the SBP drop pressure amplitude of AAV9-shRNA-ADRB1-ZsGreen
injection group were signiﬁcantly lower than the negative control group and the sham
group (22.841.72 vs.28.782.72 vs.30.165.71, P<0.05).
Conclusions: (1) The AAV9-shRNA-ADRB1-ZsGreen is successfully constructed
and it can signiﬁcantly reduce the b1-AR expression in myocardial of SHRs. (2)
Knockdown of b1-AR in myocardial tissue of Spontaneousely Hypertensive Rats
resulted in worse antihypertensive response to metoprolol; it may be one of the rea-
sons for inﬂuencing individual antihypertensive response to metoprolol.
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Expression of ZO-1 in iPS cells Mediated by Lentiviral Vector
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Objective: The fundamental researches of cardiovascular disease veriﬁed that inter-
calated disc-related gene ZO-1varis in different myocardial pathologic conditions, and
it interacts with Cx43. This research is about to construct recombinant lentivirus
over-expressing vector of porcine ZO-1 gene, to infect iPS cells, to obtain iPS cells
carrying this target gene.
Methods: The ZO-1gene sequence publicated on Gendbank was analyzed, and
designed a couple of primer containing both BamHI and SalI. The porcine ZO-1 gene
was ampliﬁed by PCR, and cloned into lentiviral expression vector, to construct the
recombinant Lenti-EF1a-EGFP-TRE-ZO1 vector; the vector was conﬁrmed by DNA
sequencing. The production of lentivirus was obtained by using pVSVG, delta
8.91and fugene to contransfect 293T cells. The titer of lentivirus was testd with
ﬂuorescent expression, to infect iPS cells.asic and Translational Medicine C43
